Literature DB >> 25451878

Isolation and characterization of cancer stem cells in renal cell carcinoma.

Giuseppe Lucarelli1, Vanessa Galleggiante, Monica Rutigliano, Antonio Vavallo, Pasquale Ditonno, Michele Battaglia.   

Abstract

Recently, several studies have investigated the presence of cancer stem cells in kidney cancer, performed characterization, and compared their profile with the normal stem cell counterparts. CD133, alone or in combination with other molecular markers, has been used to isolate normal and cancer stem cells from different sources, including renal carcinoma; however, it is still a matter of debate whether CD133+ cells really represent the main tumorigenic population within the heterogeneous pool of cancer cells that characterize this tumor. In this review, we summarize and discuss the current findings related to cancer stem cells isolation in renal cell carcinoma, focusing on controversies about their origin and the identification of a specific marker.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25451878     DOI： 10.5301/uro.5000099

Source DB:  PubMed          Journal:  Urologia        ISSN： 0391-5603


  8 in total

1.  Effects of NOTCH1 signaling inhibitor γ-secretase inhibitor II on growth of cancer stem cells.

Authors:  Xiaodong Ding; Changqing Ding; Fei Wang; Wenshuai Deng; Mingming Yu; Qinghai Meng; Peng Sun
Journal:  Oncol Lett       Date:  2018-09-03       Impact factor: 2.967

2.  Tumor-initiating cells contribute to radiation resistance in primary human renal clear cell carcinomas by activating the DNA damage checkpoint response.

Authors:  Bo Li; Yong-Ju Gao; Xin-Yu Wu; Jing Cui; Ye Long; Jun-Ling Xu; De-Gang Ding
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

Review 3.  Choosing the right cell line for renal cell cancer research.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Michal Fiedorowicz; Camillo Porta; Anna M Czarnecka
Journal:  Mol Cancer       Date:  2016-12-19       Impact factor: 27.401

4.  Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.

Authors:  Bo Cheng; Guosheng Yang; Rui Jiang; Yong Cheng; Haifan Yang; Lijun Pei; Xiaofu Qiu
Journal:  Oncotarget       Date:  2016-10-04

5.  Effect of cryopreservation on delineation of immune cell subpopulations in tumor specimens as determinated by multiparametric single cell mass cytometry analysis.

Authors:  Elma Kadić; Raymond J Moniz; Ying Huo; An Chi; Ilona Kariv
Journal:  BMC Immunol       Date:  2017-02-02       Impact factor: 3.615

6.  Human liver stem cell-derived extracellular vesicles enhance cancer stem cell sensitivity to tyrosine kinase inhibitors through Akt/mTOR/PTEN combined modulation.

Authors:  Valentina Fonsato; Michela De Lena; Stefania Tritta; Alessia Brossa; Ruggero Calvetti; Ciro Tetta; Giovanni Camussi; Benedetta Bussolati
Journal:  Oncotarget       Date:  2018-11-16

Review 7.  Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression.

Authors:  Shivani Baisiwala; Shreya Budhiraja; Chirag Goel; Khizar R Nandoliya; Miranda R Saathoff; Atique U Ahmed
Journal:  Stem Cell Rev Rep       Date:  2021-07-09       Impact factor: 6.692

8.  Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.

Authors:  Giuseppe Lucarelli; Monica Rutigliano; Francesca Sanguedolce; Vanessa Galleggiante; Andrea Giglio; Simona Cagiano; Pantaleo Bufo; Eugenio Maiorano; Domenico Ribatti; Elena Ranieri; Margherita Gigante; Loreto Gesualdo; Matteo Ferro; Ottavio de Cobelli; Carlo Buonerba; Giuseppe Di Lorenzo; Sabino De Placido; Silvano Palazzo; Carlo Bettocchi; Pasquale Ditonno; Michele Battaglia
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.